EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

CCN1 inhibition affects the function of endothelial progenitor cells under high-glucose condition

Yanting Dong, Xiaohui Zhou, Nan Zhang

Advances in Clinical and Experimental Medicine · 2023

DOI: 10.17219/acem/170998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2023. Verfasst von Yanting Dong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Cysteine-Rich Protein 61, Endothelial Progenitor Cells, Rats, Sprague-Dawley, Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of cysteine-rich angiogenic inducer 61 (Cyr61, also called CCN1) on endothelial progenitor cells (EPCs) from diabetic-rat-derived whole peripheral and bone marrow remains poorly understood. Therefore, the expression levels of CCN1, CCN1-induced C-X-C chemokine receptor type 4 (CXCR4), and stromal-cell-derived factor-1 (SDF-1) were explored under high glucose (HG) conditions. OBJECTIVES: The aim of the study was to explore the effects of high CCN1 levels on EPC activity in diabetic rats through mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway modulation. MATERIAL AND METHODS: Primary EPCs were isolated from bone marrow and whole peripheral blood of streptozocin (STZ)-induced diabetic Sprague-Dawley rats and controls. Cell migration, tube formation ability and viability were determined using transwell, Cell Counting Kit-8 (CCK-8), and Matrigel®-based capillary-like tube formation assays. Protein and gene expression levels were measured by western blot and real-time quantitative polymerase chain reaction (RT-qPCR). RESULTS: The study findings showed that EPC migration, viability and tube formation ability were significantly lower under HG conditions. High CCN1 expression levels restored EPC function by inducing SDF-1 and CXCR4 in EPCs under HG conditions. Furthermore, HG suppressed MEK/ERK phosphorylation, while an ERK1/2 agonist rescued EPC CCN1-SDF-1/CXCR4 expression under HG conditions through the activation of the MEK/ERK pathway. CONCLUSIONS: This study demonstrates that high CCN1 expression levels restored EPC functions, partly by modulating MEK/ERK signaling. These findings provide a basis for developing novel therapeutic methods for diabetic vascular neogenesis and vascular injury repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cysteine-Rich Protein 61Endothelial Progenitor CellsRats, Sprague-DawleyGlucoseReceptors, CXCR4Diabetes Mellitus, ExperimentalChemokine CXCL12Cell MovementAnimalsRatsMaleCells, CulturedMAP Kinase Signaling System

Stichwörter der Autor:innen

CCN1CXCR4EPCsSDF-1high-glucose MEK/ERK signaling pathway

Substanzen

Cysteine-Rich Protein 61GlucoseReceptors, CXCR4Chemokine CXCL12CCN1 protein, ratCxcr4 protein, ratCXCL12 protein, rat

Autor:innen und Institutionen

  • Department of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Endocrinology, Suichang County Hospital of Traditional Chinese Medicine, Lishui, China.
  • Department of Endocrinology, Huzhou Central Hospital, China.

Zitieren

APA

Dong, Y., Zhou, X., & Zhang, N. (2023). CCN1 inhibition affects the function of endothelial progenitor cells under high-glucose condition. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/170998

Vancouver

Dong Y, Zhou X, Zhang N. CCN1 inhibition affects the function of endothelial progenitor cells under high-glucose condition. Advances in Clinical and Experimental Medicine. 2023. doi:10.17219/acem/170998

BibTeX
@article{Dong2023,
  author = {Dong, Yanting and Zhou, Xiaohui and Zhang, Nan},
  title = {CCN1 inhibition affects the function of endothelial progenitor cells under high-glucose condition},
  journal = {Advances in Clinical and Experimental Medicine},
  year = {2023},
  doi = {10.17219/acem/170998}
}
Kostenlos starten →